Hemophilia Treatment Drugs Market

Hemophilia Treatment Drugs Market (Drug Class - Desmopressin, Antifibrinolytic Agents, Recombinant Coagulation Factor Concentrates, Plasma Derived Coagulation Factor Concentrates, and Fibrin Sealants; Disease Indication - Hemophilia A, Hemophilia B, and Others; Distribution Channel - E-commerce, Retail Pharmacies, and Hospital Pharmacies): Global Industry Analysis, Trends, Size, Share and Forecasts to 2026

  • Published : September, 2020

  • Rep Id : HC0477

  • Category : Healthcare & Medical Devices

  • Status : Published

Your cart contains following chapters

Chapter Chapter Name Price
Total:
Chapter No. Title/Chapter Name Price
Preface

1.1.   Report Description

1.2.   Research Methods

1.3.   Research Approaches

Free
Executive Summary

2.1.   Hemophilia Treatment Drugs Market Highlights

2.2.   Hemophilia Treatment Drugs Market Projection

2.3.   Hemophilia Treatment Drugs Market Regional Highlights

$250
Global Hemophilia Treatment Drugs Market Overview

3.1.   Introduction

3.2.   Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3.   Analysis of COVID-19 impact on the Hemophilia Treatment Drugs Market

3.4.   Porter's Five Forces Analysis

3.5.   IGR-Growth Matrix Analysis

3.5.1. IGR-Growth Matrix Analysis by Drug Class

3.5.2. IGR-Growth Matrix Analysis by Disease Indication

3.5.3. IGR-Growth Matrix Analysis by Distribution Channel

3.5.4. IGR-Growth Matrix Analysis by Region

3.6.   Value Chain Analysis of Hemophilia Treatment Drugs Market

$500
Hemophilia Treatment Drugs Market Macro Indicator Analysis
$250
Global Hemophilia Treatment Drugs Market by Drug Class

5.1.   Desmopressin

5.2.   Antifibrinolytic Agents

5.3.   Recombinant Coagulation Factor Concentrates

5.4.   Plasma Derived Coagulation Factor Concentrates

5.5.   Fibrin Sealants

$750
Global Hemophilia Treatment Drugs Market by Disease Indication

6.1.   Hemophilia A

6.2.   Hemophilia B

6.3.   Others

$750
Global Hemophilia Treatment Drugs Market by Distribution Channel

7.1.   E-commerce

7.2.   Retail Pharmacies

7.3.   Hospital Pharmacies

$750
Global Hemophilia Treatment Drugs Market by Region 2020-2026

8.1.   North America

8.1.1. North America Hemophilia Treatment Drugs Market by Drug Class

8.1.2. North America Hemophilia Treatment Drugs Market by Disease Indication

8.1.3. North America Hemophilia Treatment Drugs Market by Distribution Channel

8.1.4. North America Hemophilia Treatment Drugs Market by Country

8.2.   Europe

8.2.1. Europe Hemophilia Treatment Drugs Market by Drug Class

8.2.2. Europe Hemophilia Treatment Drugs Market by Disease Indication

8.2.3. Europe Hemophilia Treatment Drugs Market by Distribution Channel

8.2.4. Europe Hemophilia Treatment Drugs Market by Country

8.3.   Asia-Pacific

8.3.1. Asia-Pacific Hemophilia Treatment Drugs Market by Drug Class

8.3.2. Asia-Pacific Hemophilia Treatment Drugs Market by Disease Indication

8.3.3. Asia-Pacific Hemophilia Treatment Drugs Market by Distribution Channel

8.3.4. Asia-Pacific Hemophilia Treatment Drugs Market by Country

8.4.   RoW

8.4.1. RoW Hemophilia Treatment Drugs Market by Drug Class

8.4.2. RoW Hemophilia Treatment Drugs Market by Disease Indication

8.4.3. RoW Hemophilia Treatment Drugs Market by Distribution Channel

8.4.4. RoW Hemophilia Treatment Drugs Market by Sub-region

$1500
Company Profiles and Competitive Landscape

9.1.   Competitive Landscape in the Global Hemophilia Treatment Drugs Market

9.2.   Companies Profiles

9.2.1. Takeda Pharmaceutical Company Ltd

9.2.2. Biotest Aktiengesellschaft

9.2.3. Sanofi S.A.

9.2.4. Bayer AG

9.2.5. Pfizer Inc.

9.2.6. CSL Limited

9.2.7. Octapharma AG

9.2.8. F. Hoffmann-La Roche AG

9.2.9. Novo Nordisk A/S

9.2.10.   Kedrion S.p.A

$2000

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount